Studie ENDURE-CML

ENDURE-CML

EFFICACY AND SAFETY OF PEGYLATED-PROLINE- INTERFERON ALPHA 2B (AOP2014) IN MAINTAINING DEEP MOLECULAR REMISSIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) WHO DISCONTINUE ABL-KINASE INHIBITOR THERAPY - A RANDOMIZED PHASE II, MULTICENTER TRIAL WITH POST-STUDY FOLLOW-UP

3. Med 3. Med Ismaninger Str. 22 81675 München Germany

II

Rekrutierung beendet

Positiv

2017-03-21

Unbekannt / Unbekannt

Chemo